Cogent Biosciences Inc (COGT) Total Assets by Year
Cogent Biosciences Inc closed fiscal year 2025 with $937.6M in total assets, $301.2M in total liabilities and $636.4M in shareholder equity. This represents an increase of 185.9% from the prior fiscal year. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters Cogent Biosciences Inc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
COGT Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY25DEF 14A | FY24DEF 14A | FY23DEF 14A | FY22DEF 14A | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K |
|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $937.6M+185.9% | $327.9M+4.6% | $313.4M+4.2% | $300.8M+29.6% | $232.1M-7.5% | $250.9M+407.7% | $49.4M-42.5% | $85.9M+75.0% | $49.1M |
| Total Liabilities | $301.2M+320.7% | $71.6M+28.7% | $55.6M+23.4% | $45.1M+151.7% | $17.9M+10.2% | $16.2M-8.0% | $17.7M-31.3% | $25.7M-73.8% | $98.0M |
| Total Equity | $636.4M+148.3% | $256.3M-0.6% | $257.8M+0.8% | $255.7M+19.4% | $214.2M-8.7% | $234.7M+638.8% | $31.8M-47.3% | $60.2M+223.3% | -$48.8M |
COGT Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $834.5M+203.7% | $903.0M+218.2% | $937.6M+185.9% | $425.9M+10.9% | $274.8M-36.1% | $283.8M-40.4% | $327.9M+4.6% | $384.0M+8.0% | $429.9M+9.6% | $476.1M+80.9% | $313.4M+4.2% | $355.4M+7.2% |
| Total Liabilities | $302.2M+152.3% | $295.3M+355.7% | $301.2M+320.7% | $123.5M+78.0% | $119.8M+111.2% | $64.8M+20.5% | $71.6M+28.7% | $69.4M+32.0% | $56.7M+29.1% | $53.8M+35.7% | $55.6M+23.4% | $52.5M+26.3% |
| Total Equity | $532.4M+243.4% | $607.7M+177.5% | $636.4M+148.3% | $302.5M-3.9% | $155.0M-58.5% | $219.0M-48.1% | $256.3M-0.6% | $314.7M+3.9% | $373.2M+7.1% | $422.3M+88.9% | $257.8M+0.8% | $302.9M+4.5% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Cogent Biosciences Inc financials
Frequently Asked Questions
What was Cogent Biosciences Inc's total assets in fiscal year 2025?
Cogent Biosciences Inc closed fiscal year 2025 with $937.6M in total assets, $301.2M in total liabilities and $636.4M in shareholder equity.
How fast is Cogent Biosciences Inc's total assets growing?
Cogent Biosciences Inc (COGT) total assets rose by 185.9% year over year, from $327.9M to $937.6M in fiscal year 2025.
How has Cogent Biosciences Inc's total assets changed over the years?
Across the 9 fiscal years this page covers, Cogent Biosciences Inc (COGT) total assets went from $49.1M in fiscal year 2017 to $937.6M in fiscal year 2025.
What was Cogent Biosciences Inc's total assets in the most recent quarter?
Cogent Biosciences Inc (COGT) reported $834.5M in total assets in Q2 2026. This represents an increase of 203.7% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Cogent Biosciences Inc (COGT) reported on that line in every period on record.